Long Term Study of the Impact of Quantitative Molecular Monitoring of Bcr-Abl Transcripts on the Risk of Relapse of CML After Allogeneic HSCT.

被引：0
|
作者：
Arpinati, Mario
Amabile, Marilina [1 ]
Bochicchio, Maria Teresa [1 ]
Poerio, Angela [1 ]
Bandini, Giuseppe [2 ]
Bonifazi, Francesca [3 ]
Stanzani, Marta
Castagnetti, Fausto [1 ]
Rosti, Gianantonio [4 ]
Martinelli, Giovanni [4 ]
Baccarani, Michele [4 ]
机构：
[1] Univ Bologna, Dept Hematol Oncol L & A Seragnoli, Bologna, Italy
[2] Inst Hematol LA Seragnoli, Bologna, Italy
[3] Univ Bologna, Policlin S Orsola Malpighi, Ist Ematol & Oncol Med L&A Seragnoli, Bologna, Italy
[4] Univ Bologna, Dept Hematol Oncol, Bologna, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [1] A QUANTITATIVE PCR TECHNIQUE FOR MONITORING CHANGING LEVELS OF BCR-ABL TRANSCRIPTS AFTER BMT FOR CML
    CROSS, NCP
    FENG, L
    GOLDMAN, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 7 - 7
  • [2] Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia
    Arpinati, Mario
    Tolomelli, Giulia
    Bochicchio, Maria Teresa
    Castagnetti, Fausto
    Amabile, Marilina
    Bandini, Giuseppe
    Bonifazi, Francesca
    Stanzani, Marta
    Rosti, Gianantonio
    Martinelli, Giovanni
    Baccarani, Michele
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 735 - 740
  • [3] Monitoring BCR-ABL transcripts after allogeneic haematopoiteic stem cell transplant for patients with CML: is peripheral blood equivalent to bone marrow?
    Dominietto, A.
    Cirmena, G.
    Garuti, A.
    Raiola, A. M.
    Ibatici, A.
    van Lint, M.
    Patrone, F.
    Frassoni, F.
    Bacigalupo, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S66 - S66
  • [4] The association between quantitative bcr-abl mRNA burden and relapse after allogeneic transplant in 303 chronic phase CML patients.
    Oehler, VG
    Gooley, T
    Guthrie, KA
    Beppu, LW
    Radich, JP
    BLOOD, 2003, 102 (11) : 151A - 151A
  • [5] Compared molecular monitoring of BCR-ABL transcripts in peripheral blood and bone marrow samples in CML patients after allogeneic hematopoiteic stem cell transplant.
    Dominietto, Alida
    Garuti, Anna
    Raiola, Anna Maria
    Ibatici, Adalberto
    Van Lint, Maria Teresa
    Frassoni, Francesco
    Bacigalupo, Andrea
    BLOOD, 2006, 108 (11) : 427B - 427B
  • [6] Potential Pitfalls In Quantitative Real-Time PCR for Molecular Monitoring of BCR-ABL In the Management of CML
    Zhang, Hanfang
    Patel, Niren
    Kutlar, Ferdane
    Jillella, Anand P.
    Ustun, Celalettin
    Wells, Leigh G.
    Clair, Betsy
    Kutlar, Abdullah
    BLOOD, 2010, 116 (21) : 525 - 525
  • [7] Long term observation of CML patients after imatinib resistance associated with BCR-ABL mutations.
    Hochhaus, A
    Ernst, T
    Erben, P
    Mueller, MC
    Emig, M
    Kreil, S
    La Rosée, P
    Lahaye, T
    Schatz, M
    Ottmann, OG
    Schnittger, S
    Berger, U
    Hehlmann, R
    BLOOD, 2005, 106 (11) : 316A - 316A
  • [8] Therapeutical strategy based on semiquantitative BCR-ABL PCR for molecular or cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia (CML).
    Schleuning, M
    Brumme, V
    Wilmanns, W
    Kolb, HJ
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 622 - 622
  • [9] Monitoring of Dynamics of BCR-ABL Transcripts Over Time Using Digital PCR Assay In CP CML Patients After Achieving Complete Molecular Remission
    Goh, Hyun-Gyung
    Kim, Dongho
    Choi, Soo-Young
    Kim, Soo-Hyun
    Lee, Jeong
    Lee, Young-Seok
    Oh, Sang-Mi
    Kim, Dong-Wook
    BLOOD, 2010, 116 (21) : 722 - 722
  • [10] Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion
    Otazú, IB
    Tavares, RDB
    Hassan, R
    Zalcberg, I
    Tabak, DG
    Seuánez, HN
    LEUKEMIA RESEARCH, 2002, 26 (02) : 129 - 141
12345